Skip to content

Exercise as medicine for heart failure

Exercise as medicine for heart failure: A novel intervention to improve outcomes

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000174189
Enrollment
80
Registered
2019-02-06
Start date
2020-03-01
Completion date
2023-12-01
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Although impaired cardiac function initiates the syndrome, subsequent skeletal muscle and vascular abnormalities are major determinant of functional capacity and quality of life in the heart failure (HF) syndrome. Exercise based rehabilitation is a cornerstone of HF therapy. Improvements in functional capacity resulting from exercise training predict prognosis, enhance quality of life, and reduces frailty and hospitalizations. An impediment to exercise rehabilitation for heart failure patients is the early physical deconditioning which is a trademark characteristic of this patient group which can limit classical aerobic and concentric strengthening exercise prescription. The current project aims to trial a new form of exercise, utilising eccentric muscular contractions, which have unique characteristics that allows for peripheral (muscular) gains at lower oxygen consumption and promisingly suggests enhanced functional benefits at lower cardiovascular risk.

Interventions

The current project aims to trial a new form of exercise, utilising eccentric muscular contractions, which have unique characteristics that allows for peripheral (muscular) gains at lower oxygen consumption and promisingly suggests enhanced functional benefits at lower cardiovascular risk. Participants randomised to the intervention group will receive eccentric cycle training. Eccentric training of the lower limb muscles will be performed on an eccentric cycle ergometer that uses a motor to d

The current project aims to trial a new form of exercise, utilising eccentric muscular contractions, which have unique characteristics that allows for peripheral (muscular) gains at lower oxygen consumption and promisingly suggests enhanced functional benefits at lower cardiovascular risk. Participants randomised to the intervention group will receive eccentric cycle training. Eccentric training of the lower limb muscles will be performed on an eccentric cycle ergometer that uses a motor to drive a bicycle crank in reverse. The eccentric exercise will be performed over the same duration and at a cardiovascular intensity equivalent to the comparator (concentric cycling) group (up to 70% HRR). Exercise prescription will be undertaken in the Exercise Physiology Laboratory and Cardiac Gymnasia at Fiona Stanley Hospital, under the supervision of an exercise specialist with experience working with advanced HF patients. Our approach is to individually prescribe exercise predicated on baseline assessment. Exercise training is initiated one-on-one, and then continues in closely supervised small groups, to ensure strict adherence to the principles of the study’s exercise intervention. Participants will be continuously monitored with ECG telemetry. Facilities have full resuscitation equipment and rapid response, hospital accredited emergency support should that be required. The intervention is a total of 14 weeks in duration. All sessions will be supervised by an accredited exercise physiologist to ensure participant safety, and robust adherence to exercise prescription. Participants will be continuously monitored with ECG telemetry, and technique, intensity monitored by the investigators. Familiarization: Participants will undertake an initial 2-week familiarization block, of low level eccentric cycling to mitigate the potential of any exercise-induced muscle soreness or damage. Progression: Training will then be progressed over several sessions to a workload corresponding to 50% of heart rate reserve (HRR), determined during baseline aerobic capacity assessment, with further progression up to 70% HRR (as individually tolerated). Training Session format: Each group will undergo warm up and stretching routine for 10mins, followed by a total of 40mins of eccentric cycle training, then a 5min cool down. Training will occur 2 times per week. Borg’s Category Scale will be used to rate perceived exertion between the two modes of training.

Sponsors

The University of western Australia
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

NYHA Class II-IIIb with systolic dysfunction (HFrEF, EF <50%). Willing and able to sign written informed consent prior to trial entry Suitable to participate in a 14-week exercise training program, as determined by the medical history and physical examination

Exclusion criteria

Current smoking or smoking in the past 12 months, Renal impairment (stage 4 or 5 CKD), Exercise-induced ischaemia at a low workload (<3 METS), Hypertension (>165/95mmHg) Diagnosed peripheral artery disease

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026